Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institutes of Health (NIH)
Total funding amount is estimated at $2,000,000 for fiscal year 2026.
Maximum project period is 5 years.
To stimulate HIV/AIDS research within the mission of NIDDK.
Aligns with NIH HIV/AIDS research priorities.
Researchers in the field of HIV/AIDS.
Institutions focusing on diabetes, digestive, and kidney diseases.
Eligible organization types include higher education institutions, nonprofits, for-profit organizations, small businesses, local, state, and federal governments, and tribal governments.
No specific budget limits for applications.
Open to U.S. and non-U.S. entities.
Foreign organizations and non-domestic components of U.S. organizations are eligible.
Projects must align with NIDDK's mission and NIH HIV/AIDS research priorities.
Encouraged areas include gastrointestinal immunity, metabolic/endocrine function, and health-impeding social determinants.
Cost sharing is not required.
Application budgets should reflect the actual needs of the proposed project.
Applications are due by 5:00 PM local time of the applicant organization.
The earliest submission date is April 8, 2025, with the final deadline on January 7, 2028.
Applicant organizations may submit more than one application, provided each is scientifically distinct.
Duplicate applications will not be accepted.
Applications must comply with the instructions in the Research (R) Instructions in the How to Apply - Application Guide.
Applications will be evaluated based on scientific and technical merit.
Review criteria include significance, innovation, rigor, and feasibility.
Applications will undergo peer review and a second level of review by the appropriate national Advisory Council or Board.
Scientific and technical merit, availability of funds, and relevance to program priorities will be considered.
Projects must address HIV/AIDS research topics identified as priorities by NIH.
Non-responsive applications will be administratively withdrawn without review.
Collaboration with NIDDK staff is encouraged to ensure alignment with the mission.
Strong applications that address NIH-defined clinical trials may have an advantage.
Alignment with NIDDK's mission and NIH HIV/AIDS research priorities.
Submitting non-responsive applications or failing to comply with application instructions.
Engage with NIDDK staff early in the application process.
Highlight innovative approaches and the potential impact of the research.